FIRST BANK (Hamilton)
Change company Symbol lookup
Select an option...
FRBA FIRST BANK (Hamilton)
UNM Unum Group
LLY Eli Lilly and Co
BDC Belden Inc
TTM Tata Motors Ltd
HOG Harley-Davidson Inc
SKY Skyline Champion Corp
MMM 3M Co
MPX Marine Products Corp
YNDX Yandex NV
Go

Financials : Banks | Small Cap Value
Company profile

First Bank is a commercial bank. The Company provides a range of lending, deposit and other financial products and services. It operates through Community Banking segment, which is engaged in providing a range of commercial and retail and related banking services. It offers a range of lending products to meet the needs of its customers located within its market areas, including commercial and industrial loans, commercial real estate loans, residential real estate loans, and consumer and other loans. It offers a range of deposit instruments, including non-interest bearing demand deposits, interest bearing demand accounts, money market accounts, savings accounts and certificates of deposit. The Company operates approximately 18 branches located in Cinnaminson, Cranbury, Delanco, Denville, Ewing, Flemington, Hamilton, Lawrence, Pennington, Randolph, Somerset and Williamstown, New Jersey, and Doylestown, Trevose, Warminster and West Chester, Pennsylvania.

Price
Delayed
$7.85
Day's Change
0.035 (0.45%)
Bid
--
Ask
--
B/A Size
--
Day's High
7.85
Day's Low
7.70
Volume
(Heavy Day)

Today's volume of 3,466 shares is on pace to be much greater than FRBA's 10-day average volume of 14,656 shares.

3,466

Medical Microbiology Testing Technologies Global Market to 2027 - Featuring Abbott Laboratories, bioMerieux & Hologic Among Others - ResearchAndMarkets.com

7:53 am ET September 24, 2020 (BusinessWire) Print

The "Medical Microbiology Testing Technologies - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.

The publisher brings years of research experience to the 7th edition of this report. The 371-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.

Global Medical Microbiology Testing Technologies Market to Reach $3.2 Billion by 2027

Amid the COVID-19 crisis, the global market for Medical Microbiology Testing Technologies estimated at US$2.5 Billion in the year 2020, is projected to reach a revised size of US$3.2 Billion by 2027, growing at a CAGR of 3.8% over the analysis period 2020-2027.

Respiratory Diseases, one of the segments analyzed in the report, is projected to record a 4.6% CAGR and reach US$1.2 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Neurological Diseases segment is readjusted to a revised 3.2% CAGR for the next 7-year period.

The U.S. Market is Estimated at $669.8 Million, While China is Forecast to Grow at 6.9% CAGR

The Medical Microbiology Testing Technologies market in the U.S. is estimated at US$669.8 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$690.4 Million by the year 2027 trailing a CAGR of 7% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 1.2% and 2.9% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 1.9% CAGR.

Infectious Diseases Segment to Record 3.4% CAGR

In the global Infectious Diseases segment, USA, Canada, Japan, China and Europe will drive the 2.9% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$1 Billion in the year 2020 will reach a projected size of US$1.2 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$455.2 Million by the year 2027, while Latin America will expand at a 4.3% CAGR through the analysis period.

Competitors identified in this market include, among others:

Abbott Laboratories Agilent Technologies, Inc. Beckman Coulter, Inc. Becton, Dickinson and Company bioMerieux SA Bio-Rad Laboratories, Inc. F. Hoffmann-La Roche AG Himedia Laboratories Hologic, Inc. Thermo Fisher Scientific, Inc.

Key Topics Covered:

I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

Impact of Covid-19 and a Looming Global Recession Global Competitor Market Shares Medical Microbiology Testing Technologies Competitor Market Share Scenario Worldwide (in %): 2019 & 2025

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

III. MARKET ANALYSIS

IV. COMPETITION

Total Companies Profiled: 41

For more information about this report visit https://www.researchandmarkets.com/r/nrkrva

View source version on businesswire.com: https://www.businesswire.com/news/home/20200924005506/en/

SOURCE: Research and Markets

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com 
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
comtex tracking

Earnings Calendar and Events Data provided by |Terms of Use| © 2020 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2020. All rights reserved.